Cyclotron production of Gallium-68 Radiopharmaceuticals using the 68Zn(p,n)68Ga reaction and their regulatory aspects

Cyclotron production of Gallium-68 Radiopharmaceuticals using the 68Zn(p,n)68Ga reaction and their regulatory aspects

Designing and implementing various radionuclide production methods guarantees a sustainable supply, which is important for medical use. The use of medical cyclotrons for radiometal production can increase the availability of gallium-68 (68Ga) radiopharmaceuticals. Although generators have greatly in...

Full description

Bibliographic Details
Main Authors:	Ashhar, Zarif, Ahmad Fadzil, Muhammad Fakhrurazi, Othman, Muhamad Faiz, Yusof, Nor Azah, Abdul Onny, Muhammad Adib, Mat Ail, Noratikah, Abd Rahman, Siti Fatimah
Format:	Article
Published:	MDPI 2022

Similar Items

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
by: Zarif Ashhar, et al.
Published: (2022-12-01)

Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron
by: Ashhar, Zarif, et al.
Published: (2024)

Gallium radiopharmaceuticals 68
by: José Morín Zorrilla, et al.
Published: (2012-01-01)

Fully Automated Production of [<sup>68</sup>Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
by: Alexandra I. Fonseca, et al.
Published: (2023-10-01)

Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
by: Adam J. Rosenberg, et al.
Published: (2023-10-01)

Good practices for 68Ga radiopharmaceutical production
by: Bryce J. B. Nelson, et al.
Published: (2022-10-01)

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020-11-01)

68Ga-Based Radiopharmaceuticals: Production and Application Relationship
by: Irina Velikyan
Published: (2015-07-01)

Preparation and characterization of [68Ga]NODAGA-Pamidronic acid for pet bone cancer imaging
by: Mohd Ashhar, Zarif Naim
Published: (2020)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
by: Ruslan Cusnir, et al.
Published: (2017-01-01)

A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.
by: Vijay Sharma, et al.
Published: (2014-01-01)

Development of an Automated Synthesizer for the Routine Production of Ga-68 Radiopharmaceuticals
by: Jun Young PARK, et al.
Published: (2023-12-01)

Good practices for Ga-68 radiopharmaceutical production: an important correction
by: Aziz Gültekin
Published: (2023-01-01)

New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
by: I. F. Antunes, et al.
Published: (2020-05-01)

Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
by: Jean-Philippe Sinnes, et al.
Published: (2019-05-01)

Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
by: Elke A. van Brandwijk, et al.
Published: (2024-04-01)

PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga
by: Scott M. Thompson, et al.
Published: (2022-05-01)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01)

Impurity of Gallium-［68Ga］ Chloride Solution from Generator
by: WU Fuhai1,2,3;CHEN Mengyi1,2,3;WANG Xiaoming1,2,3;WANG Chunlin1,2,3;SUN Mingyue1,2,3;QIU Shanshan1,2,3;ZHOU Jiajun1,2,3;QIN Xiangyu1,2,3;SHEN Langtao1,2,3
Published: (2023-10-01)

Application of the 68Ge/68Ga Generator in Clinic
by: HUANG Qian-huan1;PAN Dong-hui2;XU Yu-ping2;SHENG Jie1;WANG Yan-ting2;YANG Min1,2
Published: (2017-04-01)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023-11-01)

Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.
by: María Luisa Soto-Montenegro, et al.
Published: (2014-01-01)

Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study
by: Courtney Lawhn-Heath, et al.
Published: (2020-10-01)

Preparation of Ga/Ni Solid Target for Cyclotron-Produced 68Ge by Electrodeposition
by: SHEN Yi-jia1,2;FU Hong-yu1;LUO Wen-bo1;DENG Xue-song1;LIU Yu-ping1;LI Guang1;XU Hong-wei1,2;WANG Gang1
Published: (2014-02-01)

Gallium‐68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience
by: Alireza Aslani, et al.
Published: (2014-10-01)

Detection of neuroendocrine tumour of sphenoid sinus on the Gallium-68 DOTATATE PET/CT: a rare entity
by: Shamim, Syed Ejaz, et al.
Published: (2022)

Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
by: Emma Jussing, et al.
Published: (2021-07-01)

Artificial intelligence-based 68Ga-DOTATOC PET denoising for optimizing 68Ge/68Ga generator use throughout its lifetime
by: Elske Quak, et al.
Published: (2023-03-01)

Characterization of 68Ge/68Ga Generator and Quality Control of its Eluate
by: S Zolghadri, et al.
Published: (2018-08-01)

The Current Development Status of 68Ge-68Ga Generators for Medical Use
by: LI Long;ZHOU Sai;DING Songdong;HUANG Yong
Published: (2023-02-01)

Preparation, characterization, and radiolabeling of [68Ga]Nodaga-pamidronic acid: a potential PET bone imaging agent
by: Ashhar, Zarif, et al.
Published: (2020)

The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
by: Brian Gaffney, et al.
Published: (2021-10-01)

Preparation, Characterization, and Radiolabeling of [<sup>68</sup>Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent
by: Zarif Ashhar, et al.
Published: (2020-06-01)

A Specific HPLC Method to Determine Residual HEPES in [<sup>68</sup>Ga]Ga-Radiopharmaceuticals: Development and Validation
by: Silvia Migliari, et al.
Published: (2022-07-01)

Semiquantitative Analysis of Physiological Biodistribution of <sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-DOTANOC
by: Evrim SÜRER BUDAK, et al.
Published: (2023-07-01)

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial
by: Juana Martinez, et al.
Published: (2023-02-01)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
by: Simon A. M. Kaeppeli, et al.
Published: (2019-05-01)

Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors
by: Damiano Librizzi, et al.
Published: (2023-03-01)

Synthesis, Complexation Properties, and Evaluation of New Aminodiphosphonic Acids as Vector Molecules for <sup>68</sup>Ga Radiopharmaceuticals
by: Alesya Ya. Maruk, et al.
Published: (2021-04-01)

68Ga–Prostate-Specific Membrane Antigen: A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma
by: Rita Chahinian, et al.
Published: (2020-07-01)